Curvature-Encoded Photochemistry for Programmable Isolation and Fractionation of Extracellular and Plasma Membrane Vesicles
AbstractLipid-based nanoparticles, including extracellular vesicles (EVs), cell membrane vesicles (CMVs), and biomimetic nanovesicles, are emerging as powerful carriers for therapy and diagnosis due to their ability to transport diverse payloads across biological barriers. EVs, in particular, show promise for liquid biopsy and systemic therapy because of their endogenous origin, biocompatibility, and intrinsic targeting capacity. Cell-derived plasma membrane nanovesicles complement EVs by preserving the source cells membrane architecture and receptor landscape, creating customizable scaffolds for biomimetic drug delivery. However, the full potential of these lipid nanovesicles has been challenging because current isolation workflows are labor-intensive, low-yield, and often lack purity, forming a critical bottleneck for clinical translation and standardized manufacturing. To overcome these challenges, we developed a programmable electrostatic and light-activated platform for isolating lipid vesicles directly from complex biological fluids in a rapid, high-purity, and scalable manner. Our approach employs photocleavable lipid nanoprobes (PLNs) that insert into vesicle membranes in a size-dependent fashion and, together with a cationic polymer, enable efficient capture on a solid support. A brief light exposure cleaves the probes to trigger on-demand release and fractionation of intact vesicles with high speed and precision. Using this platform, we demonstrate high-purity EV isolation with preserved membrane protein functionality, as well as single-step enrichment of right-side-out (RSO) cell membrane nanovesicles that maintain native membrane orientation for effective drug delivery. The capability to rapidly isolate and tailor vesicle subpopulations by size and orientation establishes a unified materials platform for precision nanomedicine and advanced therapeutics, paving the way toward clinical-grade vesicle production and next-generation liquid biopsy applications.